Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 1/20 | 0.49 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | GSK3A | P49840 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28545719 | 0.84 | ALDH1A1 (0.50) | TYMPP2RX4IDO1SRCSIGMAR1 | |
| SCHEMBL3015728 | 0.76 | TYMP (0.54) | TYMPP2RX4IDO1SRCSIGMAR1 | |
| SCHEMBL28132698 | 0.76 | MAP2K1 (0.35) | ALDH1A1MAPTPOLBKMT2ANAPRT | |
| SCHEMBL11560902 | 0.74 | TSHR (0.47) | TYMPP2RX4IDO1SIGMAR1GSK3A | |
| SCHEMBL2899212 | 0.74 | TYMP (0.45) | TYMPP2RX4IDO1SRCSIGMAR1 | |
| SCHEMBL11792243 | 0.73 | P2RX4 (0.59) | TYMPP2RX4IDO1SRCSIGMAR1 | |
| SCHEMBL31621004 | 0.73 | TYMP (0.60) | TYMPP2RX4IDO1SRCSIGMAR1 | |
| SCHEMBL28393438 | 0.73 | CYP3A4 (0.51) | IDO1ALDH1A1MAPTPOLBKMT2A | |
| SCHEMBL5860460 | 0.73 | LMNA (0.49) | GSK3AGSK3BALDH1A1MAPTKMT2A | |
| SCHEMBL3676684 | 0.72 | SIGMAR1 (0.42) | TYMPP2RX4IDO1SIGMAR1GSK3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678646-A1 | NUCLEOSIDE ANALOG FOR 5'-PHOSPHONATE MODIFICATION AND OLIGONUCLEOTIDE PREPARED THEREFROM | Shanghai Argo Biopharmaceutical Co., Ltd. (CN) | 2026-01-14 | — | — | EP | claimed |
| WO-2024208249-A1 | NUCLEOSIDE ANALOG FOR 5'-PHOSPHONATE MODIFICATION AND OLIGONUCLEOTIDE PREPARED THEREFROM | 上海舶望制药有限公司 | 2024-10-10 | — | — | WO | claimed |
| US-20130310403-A1 | Fluoro-homoneplanocin A and nucleoside derivatives, method for the synthesis thereof, and the pharmaceutical compositions comprising the same as an active component for treatment of cancer | EWHA UNIVERSITY - INDUSTRY COLABORATION FOUNDATION (KR) | 2013-11-21 | — | — | US | claimed |
| US-20020072586-A1 | Chiral peptide nucleic acids | ISIS INNOVATION LIMITED (GB) | 2002-06-13 | — | — | US | claimed |
| US-6403763-B1 | Chiral peptide nucleic acids | ISIS INNOVATION LIMITED (GB) | 2002-06-11 | — | — | US | claimed |
| EP-0956297-A1 | CHIRAL PEPTIDE NUCLEIC ACIDS | ISIS INNOVATION LIMITED (GB) | 1999-11-17 | — | — | EP | claimed |
| WO-1998016550-A1 | CHIRAL PEPTIDE NUCLEIC ACIDS | ISIS INNOVATION LIMITED (GB) | 1998-04-23 | — | — | WO | claimed |
| US-4914105-A | NONTOXIC, REDUCED SIDE EFFECTS | FUJII SETSURO (JP) | 1990-04-03 | — | — | US | claimed |
| JP-58198500-A | — | — | None | — | — | JP | disclosed |
| WO-2026098737-A1 | NUCLEIC ACID CONJUGATE AND PHARMACEUTICAL COMPOSITION FOR LIPID DELIVERY, AND USE THEREOF | 苏州时安生物技术有限公司 | 2026-05-15 | — | — | WO | disclosed |
| WO-2026098677-A1 | DOUBLE-STRANDED RNA FOR REGULATING ALK7 EXPRESSION, CONJUGATE THEREOF, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | 苏州时安生物技术有限公司 | 2026-05-15 | — | — | WO | disclosed |
| WO-2026101522-A1 | 2'-FLUORO-6'METHYLENE CARBOCYCLIC NUCLEOSIDES AND NUCLEOTIDES AND METHODS OF TREATING POXVIRUS INFECTIONS WITH SAME | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260108546-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
| JP-S58198500-A | RIBONUCLEOSIDE SUBSTITUTED WITH 4-METHOXYBENZYL GROUP IN THE 2'-POSITION | MITSUI TOATSU CHEM INC | 1983-11-18 | — | — | JP | disclosed |
| EP-0045944-B1 | ENHANCER OF ANTI-TUMOR EFFECT | Yamasa Shoyu Kabushiki Kaisha (JP) | 1983-08-31 | — | — | EP | disclosed |
| EP-0079054-A1 | Enhancer of antitumor effect | Yamasa Shoyu Kabushiki Kaisha (JP) | 1983-05-18 | — | — | EP | disclosed |
| EP-0068268-A1 | Enhancer of anti-tumour effect | Yamasa Shoyu Kabushiki Kaisha (JP) | 1983-01-05 | — | — | EP | disclosed |
| EP-0048022-A2 | Enhancer of anti-tumor effect | Yamasa Shoyu Kabushiki Kaisha (JP) | 1982-03-24 | — | — | EP | disclosed |
| EP-0045944-A1 | Enhancer of anti-tumor effect | Yamasa Shoyu Kabushiki Kaisha (JP) | 1982-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130310403-A1 | Fluoro-homoneplanocin A and nucleoside derivatives, method for the synthesis thereof, and the pharmaceutical compositions comprising the same as an active component for treatment of cancer | NME1, NTPCR, ENTPD5 | TYMP 45/4885P2RX4 1835/4885IDO1 4647/4885 |
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | TYMP 4811/4885P2RX4 402/4885IDO1 1978/4885 |
| US-20260108546-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GCGR | TYMP 4798/4885P2RX4 433/4885IDO1 2592/4885 |
| US-20020072586-A1 | Chiral peptide nucleic acids | POLL, HNRNPL, HLA-B | TYMP 467/4885P2RX4 4504/4885IDO1 2154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.